Piedmont Lithium Inc. (PLLTL)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -26.44 Million | -16.25 Million | -9.8 Million | -7.58 Million | -1.76 Million | -553.36 Thousand |
| Net Income | -12.97 Million | -19.99 Million | -9.82 Million | -9.95 Million | -2.68 Million | -286.74 Thousand |
| Depreciation & Amortization | 73.69 Thousand | 11.58 Thousand | 8812.00 | 1259.00 | 1501.00 | 7451.00 |
| Deferred income taxes | 3.13 Million | 64.62 Thousand | - | - | - | - |
| Stock-based compensation | 3.48 Million | 1.31 Million | 438.37 Thousand | 1.17 Million | - | - |
| Change in working capital | 277.87 Thousand | 2.19 Million | -200.28 Thousand | 1.25 Million | - | - |
| Other non-cash items | -20.45 Million | 143.73 Thousand | -234.09 Thousand | -52.53 Thousand | 921.86 Thousand | -274.06 Thousand |
| Investing Cash Flow | -59.8 Million | -34.56 Million | -1.55 Million | -598.5 Thousand | -185.21 Thousand | 79.87 Thousand |
| Investments in PPE | -25.73 Million | -18.2 Million | -1.53 Million | -1337.79 | -4130.42 | - |
| Acquisitions | -34.06 Million | -16.35 Million | - | - | - | - |
| Investment purchases | -43.6 Million | - | - | -36.39 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 79.87 Thousand |
| Other Investing Activities | 43.6 Million | - | -15 Thousand | -560.77 Thousand | -181.08 Thousand | - |
| Financing Cash Flow | 121.25 Million | 174.61 Million | 8.32 Million | 11.76 Million | 3.64 Million | - |
| Debt repayment | -1.08 Million | -695.57 Thousand | -435.53 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -310.98 Thousand | - |
| Common Stock Issuance | 122.05 Million | 174.96 Million | 8.83 Million | 12.41 Million | 3.88 Million | - |
| Other Financing Activities | 279.02 Thousand | 349.04 Thousand | -74.33 Thousand | -653.7 Thousand | 72 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.41 Million | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.13 Million | - | -200.28 Thousand | 1.25 Million | - | - |
| Cash at beginning of period | 64.24 Million | 18.85 Million | 7.23 Million | 3.51 Million | 1.42 Million | 1.71 Million |
| Cash at end of period | 99.24 Million | 142.65 Million | 4.43 Million | 7.19 Million | 3.53 Million | 1.38 Million |
| Capital Expenditure | -25.73 Million | -18.2 Million | -1.53 Million | -1337.79 | -4130.42 | - |
| Effect of forex changes on cash | - | - | 234.09 Thousand | 52.21 Thousand | -630.13 | - |
| Net cash flow / Change in cash | 35 Million | 123.79 Million | -2.8 Million | 3.67 Million | 2.1 Million | -333.36 Thousand |
| Free Cash Flow | -52.18 Million | -34.46 Million | -11.34 Million | -7.58 Million | -1.76 Million | -553.36 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.89 Million | -10.63 Million | -8.63 Million | -12.97 Million | -10.9 Million | 16.66 Million |
| Depreciation & Amortization | 68.2 Thousand | 60.78 Thousand | 45.01 Thousand | 73.69 Thousand | 41.22 Thousand | 21.26 Thousand |
| Deferred income taxes | 2.02 Million | 648.81 Thousand | 493.34 Thousand | 3.13 Million | -282.95 Thousand | - |
| Stock-based compensation | 3.06 Million | 3.18 Million | 1.12 Million | 3.48 Million | 846.53 Thousand | 1.26 Million |
| Change in working capital | 8.75 Million | -2.19 Million | -2.04 Million | 277.87 Thousand | 3.66 Million | 1.76 Million |
| Other non-cash items | -11.72 Million | -1.23 Million | -489.16 Thousand | -20.45 Million | 2.22 Million | -23.9 Million |
| Investing Cash Flow | -18.81 Million | -30.17 Million | -31.47 Million | -59.8 Million | -14 Million | -17.1 Million |
| Investments in PPE | -16.28 Million | -10.17 Million | -18.51 Million | -25.73 Million | -3.83 Million | -10.35 Million |
| Acquisitions | -449.42 Thousand | -16.12 Million | -12.09 Million | -34.06 Million | -10.16 Million | -13.84 Million |
| Investment purchases | - | - | -12091.52 Billion | -43.6 Million | -43.6 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -18.36 Million | -3.87 Million | 12091.52 Billion | 43.6 Million | 43.6 Million | 7.09 Million |
| Financing Cash Flow | -527.19 Thousand | -121.27 Thousand | 70.96 Million | 121.25 Million | 71.04 Thousand | -150.99 Thousand |
| Debt repayment | -104.8 Thousand | -121.27 Thousand | -117.92 Thousand | -1.08 Million | -114.66 Thousand | -150.99 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -389.00 | - | 71.08 Million | 122.05 Million | 122059.23 Billion | - |
| Other Financing Activities | -422 Thousand | - | - | 279.02 Thousand | -122059.23 Billion | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 22.93 Million | -411.77 Thousand | -660.76 Thousand | 1.41 Million | 1.14 Million | 756.63 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -14.17 Million | -1.78 Million | -1.38 Million | -1.13 Million | 2.51 Million | 1.01 Million |
| Cash at beginning of period | 88.74 Million | 129.22 Million | 99.24 Million | 64.24 Million | 117.58 Million | 139.03 Million |
| Cash at end of period | 94.49 Million | 88.74 Million | 129.22 Million | 99.24 Million | 99.24 Million | 117.58 Million |
| Capital Expenditure | -16.28 Million | -10.17 Million | -18.51 Million | -25.73 Million | -3.83 Million | -10.35 Million |
| Effect of forex changes on cash | - | -10639.09 Billion | - | - | - | - |
| Net cash flow / Change in cash | 5.74 Million | -40.47 Million | 29.97 Million | 35 Million | -18.34 Million | -21.44 Million |
| Free Cash Flow | 8.8 Million | -20.35 Million | -28.03 Million | -52.18 Million | -8.24 Million | -14.54 Million |
SEMAC
JAGSNPHARM
6262
BEIJF
300042
INNOCORP